Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation

References

• Alonso Pérez JL, Martín Pérez S, Battaglino A, et al. An up-date of the muscle strengthening exercise effectiveness in postmenopausal women with osteoporosis: a qualitative systematic review. J Clin Med. 2021;10(11):2229.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Z. Ovarian aging and osteoporosis. Adv Exp Med Biol. 2018;1086:199–215.
   PubMed Web of Science ®Google Scholar
• Cipriani C, Pepe J, Bertoldo F, et al. The epidemiology of osteoporosis in Italian postmenopausal women according to the national bone health alliance (NBHA) diagnostic criteria: a multicenter cohort study. J Endocrinol Invest. 2018;41(4):431–438.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Anastasilakis AD, Efstathiadou ZA, et al. Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas. 2021;147:19–25.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li Y, Zhang M, et al. Blood lipid levels in patients with osteopenia and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab. 2021;39(3):510–520.
   PubMed Web of Science ®Google Scholar
• Chen YY, Wang WW, Yang L, et al. Association between lipid profiles and osteoporosis in postmenopausal women: a Meta-analysis. Eur Rev Med Pharmacol Sci. 2018;22(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hung TY, Chen TL, Liao MH, et al. Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. J Ethnopharmacol. 2010;131(1):70–77.
   PubMed Web of Science ®Google Scholar
• Yin FM, Xiao LB, Zhang Y. Research progress on Drynaria fortunei naringin on inflammation and bone activity. Zhongguo Gu Shang. 2015;28(2):182–186. PMID: 25924506.
   PubMedGoogle Scholar
• Gan D, Xu X, Chen D, et al. Network pharmacology-based pharmacological mechanism of the Chinese medicine rhizoma drynariae against osteoporosis. Med Sci Monit. 2019;25:5700–5716.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang J, Shen H, et al. Total flavonoids from rhizoma Drynariae (gusuibu) for treating osteoporotic fractures: implication in clinical practice. Drug Des Devel Ther. 2017;11:1881–1890.
   PubMed Web of Science ®Google Scholar
• Lin H, Wang X, Wang L, et al. Identified the synergistic mechanism of Drynariae rhizoma for treating fracture based on network pharmacology. Evid Based Complement Alternat Med. 2019;2019:7342635.
   PubMed Web of Science ®Google Scholar
• Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16(1):7–21.
   PubMed Web of Science ®Google Scholar
• Gaidt MM, Hornung V. The NLRP3 inflammasome renders cell death pro-inflammatory. J Mol Biol. 2018;430(2):133–141.
   PubMed Web of Science ®Google Scholar
• Brydges SD, Broderick L, McGeough MD, et al. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. J Clin Invest. 2013;123(11):4695–4705.
   PubMed Web of Science ®Google Scholar
• Fang H, Zhang H, Wang Z, et al. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal. 2020;34(1):e23016.
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Aziz I, Yakout S, et al. Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine (Baltimore). 2017;96(4):e5780.
   PubMed Web of Science ®Google Scholar
• Huang ST, Chang CC, Pang JS, et al. Drynaria fortunei promoted angiogenesis associated with modified MMP-2/TIMP-2 balance and activation of VEGF ligand/receptors expression. Front Pharmacol. 2018;9:979.
   PubMed Web of Science ®Google Scholar
• Sun W, Li M, Xie L, et al. Exploring the mechanism of total flavonoids of Drynariae rhizoma to improve large bone defects by network pharmacology and experimental assessment. Front Pharmacol. 2021;12:603734.
   PubMed Web of Science ®Google Scholar
• Youngquist ST, Shah AP, Rosborough JP, et al. High serum tumor necrosis factor levels in the early post-cardiac arrest period are associated with poor short-term survival in a swine model of ventricular fibrillation. J Interferon Cytokine Res. 2016;36(10):575–579.
   PubMed Web of Science ®Google Scholar
• Howell KW, Cleveland JC, Jr, Meng X, et al. Interleukin 6 production during cardiac surgery correlates with increasing age. J Surg Res. 2016;201(1):76–81.
   PubMed Web of Science ®Google Scholar
• Dagdeviren S, Jung DY, Friedline RH, et al. IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle. FASEB J. 2017;31(2):701–710.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Netea MG, Dinarello CA, et al. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 2011;32(3):110–116.
   PubMed Web of Science ®Google Scholar
• Zhang P, Tsuchiya K, Kinoshita T, et al. Vitamin B6 prevents IL-1β protein production by inhibiting NLRP3 inflammasome activation. J Biol Chem. 2016;291(47):24517–24527.
   PubMed Web of Science ®Google Scholar
• Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296–307.
   PubMed Web of Science ®Google Scholar
• Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann NY Acad Sci. 2014;1319:82–95.
   PubMed Web of Science ®Google Scholar
• Afonina IS12, Zhong Z4, Karin M, et al. Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol. 2017;18(8):861–869.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhao X, Yang S, et al. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway. Chem Biol Interact. 2017;278:48–53.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang X, He Y, et al. Negative regulation of NLRP3 inflammasome by SIRT1 in vascular endothelial cells. Immunobiology. 2017;222(3):552–561.
   PubMed Web of Science ®Google Scholar
• Ma CH, Kang LL, Ren HM, et al. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats. J Ethnopharmacol. 2015;172:108–117.
   PubMed Web of Science ®Google Scholar
• Koka S, Xia M, Chen Y, et al. Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia. Redox Biol. 2017;13:336–344.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zheng Q, Chen J, et al. FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis. Exp Cell Res. 2020;393(2):112108.
   PubMed Web of Science ®Google Scholar
• Briot A, Civelek M, Seki A, et al. Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis. J Exp Med. 2015;212(12):2147–2163.
   PubMed Web of Science ®Google Scholar
• Chandiran K, Lawlor R, Pannuti A, et al. Notch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29. Mol Immunol. 2018;99:191–198.
   PubMed Web of Science ®Google Scholar